In the trial, the patients will smoke X-22 for a duration of six weeks time period with an aim to stop smoking by the end of 6 weeks.
X-22 consists of a kit of very low nicotine (VLN) cigarettes made from 22nd Century’s proprietary tobacco.
The trial aims to compare quit rates of patients using X-22 cigarettes with quit rates of those using active control cigarettes with conventional nicotine content.